These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30765945)

  • 1. Hepatic Encephalopathy and Sarcopenia: Two Faces of the Same Metabolic Alteration.
    Lattanzi B; D'Ambrosio D; Merli M
    J Clin Exp Hepatol; 2019; 9(1):125-130. PubMed ID: 30765945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
    Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
    Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
    Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
    Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
    Kawaguchi T; Taniguchi E; Sata M
    Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Gioia S; Ridola L; Cristofaro L; Merli M; Faccioli J; Riggio O; Nardelli S
    Liver Int; 2021 Dec; 41(12):2965-2973. PubMed ID: 34543504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
    Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
    Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition and Muscle in Cirrhosis.
    Anand AC
    J Clin Exp Hepatol; 2017 Dec; 7(4):340-357. PubMed ID: 29234200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts.
    Nardelli S; Riggio O; Gioia S; Merli M; Spagnoli A; di Martino M; Pelle G; Ridola L
    Dig Liver Dis; 2022 Aug; 54(8):1060-1065. PubMed ID: 35058135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.
    Berenguer M
    Acta Gastroenterol Belg; 2023; 86(2):318-322. PubMed ID: 37428165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis.
    Li Y; Guo Y; Wang X; Gao L
    Abdom Radiol (NY); 2024 Feb; 49(2):575-585. PubMed ID: 37980601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.
    Hanai T; Shiraki M; Watanabe S; Kochi T; Imai K; Suetsugu A; Takai K; Moriwaki H; Shimizu M
    Hepatol Res; 2017 Dec; 47(13):1359-1367. PubMed ID: 28199774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
    Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Ronald J; Bozdogan E; Zaki IH; Kappus MR; Choi SS; Martin JG; Suhocki PV; Smith TP; Kim CY; Bashir MR
    AJR Am J Roentgenol; 2020 Jan; 214(1):200-205. PubMed ID: 31670594
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
    Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    World J Gastroenterol; 2019 Sep; 25(35):5257-5265. PubMed ID: 31558871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.